Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avenue Venture Opportunities Fund I is a specialized investment vehicle managed by Avenue Capital Group that focuses on providing growth capital to companies within the life sciences and technology sectors. The fund primarily utilizes venture debt and equity investments to support mid-to-late-stage companies that have established clinical or commercial milestones. Its investment strategy is designed to provide flexible financing solutions to innovative healthcare firms, enabling them to scale operations, fund clinical trials, or expand market reach. The fund leverages the broader Avenue Capital platform to identify high-growth opportunities in biotechnology, medical devices, and healthcare services. By bridging the gap between early-stage venture capital and traditional financing, the fund plays a critical role in the commercialization of medical innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avenue Venture Opportunities Fund I.